• Jaguar Health received Nasdaq Hearings Panel extension to May 18, 2026 to regain compliance with Nasdaq $1 minimum bid price rule.
• Non-compliance clock reset after Nasdaq staff flagged failure to meet minimum 500,000 publicly held shares requirement on May 1, 2026.
• Company regained compliance with publicly held shares rule following May 4, 2026 exercise of pre-funded warrants by third-party investors.
• Nasdaq requires closing bid price of at least $1 for at least 10 consecutive business days to cure bid price deficiency.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605080900ACCESSWRNAPR_____1165275) on May 08, 2026, and is solely responsible for the information contained therein.